NDC Package 70860-403-51 Bivalirudin Rtu

Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70860-403-51
Package Description:
10 CARTON in 1 CARTON / 1 VIAL, SINGLE-DOSE in 1 CARTON (70860-403-50) / 50 mL in 1 VIAL, SINGLE-DOSE
Product Code:
Proprietary Name:
Bivalirudin Rtu
Non-Proprietary Name:
Bivalirudin
Substance Name:
Bivalirudin
Usage Information:
Bivalirudin RTU Injection is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI), including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
11-Digit NDC Billing Format:
70860040351
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1997015 - bivalirudin 250 MG in 50 ML Injection
  • RxCUI: 1997015 - 50 ML bivalirudin 5 MG/ML Injection
  • RxCUI: 1997015 - bivalirudin 250 MG (as bivalirudin trifluoroacetate 275 MG) per 50 ML Injection
  • RxCUI: 1997015 - bivalirudin 250 MG per 50 ML Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Athenex Pharmaceutical Division, Llc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA211215
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    03-01-2020
    End Marketing Date:
    06-26-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 70860-403-51?

    The NDC Packaged Code 70860-403-51 is assigned to a package of 10 carton in 1 carton / 1 vial, single-dose in 1 carton (70860-403-50) / 50 ml in 1 vial, single-dose of Bivalirudin Rtu, a human prescription drug labeled by Athenex Pharmaceutical Division, Llc.. The product's dosage form is injection, solution and is administered via intravenous form.

    Is NDC 70860-403 included in the NDC Directory?

    Yes, Bivalirudin Rtu with product code 70860-403 is active and included in the NDC Directory. The product was first marketed by Athenex Pharmaceutical Division, Llc. on March 01, 2020.

    What is the NDC billing unit for package 70860-403-51?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 70860-403-51?

    The 11-digit format is 70860040351. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-270860-403-515-4-270860-0403-51